{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:44Z","timestamp":1760853764792},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Coordination, Rationalization, and Integration of antiMALarial drug Discovery &amp; Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite the discovery of new anti-malarials. This paper outlines the recommendations for the development of enabling technologies and the identification of novel targets.<\/jats:p><jats:p>Screening systems must be robust, validated, reproducible, and represent human malaria. They also need to be cost-effective. While such systems exist to screen for activity against blood stage<jats:italic>Plasmodium falciparum<\/jats:italic>, they are lacking for other<jats:italic>Plasmodium<\/jats:italic>spp. and other stages of the parasite\u2019s life cycle. Priority needs to be given to developing high-throughput screens that can identify activity against the liver and sexual stages. This in turn requires other enabling technologies to be developed to allow the study of these stages and to allow for the culture of liver cells and the parasite at all stages of its life cycle.<\/jats:p><jats:p>As these enabling technologies become available, they will allow novel drug targets to be studied. Currently anti-malarials are mostly targeting the asexual blood stage of the parasite\u2019s life cycle. There are many other attractive targets that need to be investigated. The liver stages and the sexual stages will become more important as malaria control moves towards malaria elimination. Sexual development is a process offering multiple targets, even though the mechanisms of differentiation are still not fully understood. However, designing a drug whose effect is not curative but would be used in asymptomatic patients is difficult given current safety thresholds. Compounds active against the liver schizont would have a prophylactic effect and<jats:italic>Plasmodium vivax<\/jats:italic>elimination requires effectors against the dormant liver hypnozoites. It may be that drugs to be used in elimination campaigns will also need to have utility in the control phase. Compounds with activity against blood stages need to be screened for activity against other stages.<\/jats:p><jats:p>Natural products should also be a valuable source of new compounds. They often occupy non-Lipinski chemical space and so may reveal valuable new chemotypes.<\/jats:p>","DOI":"10.1186\/1475-2875-12-396","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T16:39:51Z","timestamp":1383669591000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CRIMALDDI: platform technologies and novel anti-malarial drug targets"],"prefix":"10.1186","volume":"12","author":[{"given":"Henri","family":"Vial","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Taramelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve A","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Doerig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Chibale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,5]]},"reference":[{"key":"3004_CR1","doi-asserted-by":"publisher","first-page":"e1000406","DOI":"10.1371\/journal.pmed.1000406","volume":"8","author":"PL Alonso","year":"2011","unstructured":"Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM, Mendis K, Newman RD, Plowe CV, Rodr\u00edguez MH, Sinden R, Slutsker L, Tanner M: A research agenda to underpin malaria eradication. PLoS Med. 2011, 8: e1000406-10.1371\/journal.pmed.1000406.","journal-title":"PLoS Med"},{"key":"3004_CR2","volume-title":"Global malaria action plan","author":"Roll Back Malaria Partnership","year":"2008","unstructured":"Roll Back Malaria Partnership: Global malaria action plan. 2008, Geneva: RBM Partnership"},{"key":"3004_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/hv.6.1.9604","volume":"6","author":"RE Sinden","year":"2010","unstructured":"Sinden RE: A biologist\u2019s perspective on malaria vaccine development. Hum Vaccin. 2010, 6: 3-11. 10.4161\/hv.6.1.9604.","journal-title":"Hum Vaccin"},{"key":"3004_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","volume":"26","author":"TN Wells","year":"2010","unstructured":"Wells TN, Burrows JN, Baird JK: Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 2010, 26: 145-151. 10.1016\/j.pt.2009.12.005.","journal-title":"Trends Parasitol"},{"key":"3004_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1475-2875-9-202","volume":"9","author":"IC Boulton","year":"2010","unstructured":"Boulton IC, Nwaka S, Bathurst I, Lanzer M, Taramelli D, Vial H, Doerig C, Chibale K, Ward SA: CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives. Malar J. 2010, 9: 202-10.1186\/1475-2875-9-202.","journal-title":"Malar J"},{"key":"3004_CR6","unstructured":"CRIMALDDI: The Coordination, Rationalization, and Integration of Antimalarial Drug Discovery & Development Initiatives.http:\/\/www.crimalddi.eu,"},{"key":"3004_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1475-2875-12-395","volume":"12","author":"SA Ward","year":"2013","unstructured":"Ward SA, Boulton IC: CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs. Malar J. 2013, 12: 395-10.1186\/1475-2875-12-395.","journal-title":"Malar J"},{"key":"3004_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/415686a","volume":"415","author":"RG Ridley","year":"2002","unstructured":"Ridley RG: Medical need, scientific opportunity and the drive for antimalarial drugs. Nature. 2002, 415: 686-693. 10.1038\/415686a.","journal-title":"Nature"},{"key":"3004_CR9","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1128\/AAC.02350-12","volume":"57","author":"CJ Woodrow","year":"2013","unstructured":"Woodrow CJ, Dahlstr\u00f6m S, Cooksey R, Flegg JA, Le Nagard H, Mentr\u00e9 F, Murillo C, M\u00e9nard D, Nosten F, Sriprawat K, Musset L, Quashie NB, Lim P, Fairhurst RM, Nsobya SL, Sinou V, Noedl H, Pradines B, Johnson JD, Guerin PJ, Sibley CH, Le Bras J: High-throughput analysis of antimalarial susceptibility data by the worldwide antimalarial resistance network (WWARN) in vitro analysis and reporting tool. Antimicrob Agents Chemother. 2013, 57: 3121-3130. 10.1128\/AAC.02350-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"3004_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979, 16: 710-718. 10.1128\/AAC.16.6.710.","journal-title":"Antimicrob Agents Chemother"},{"key":"3004_CR11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","volume":"48","author":"MT Makler","year":"1993","unstructured":"Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ: Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg. 1993, 48: 739-741.","journal-title":"Am J Trop Med Hyg"},{"key":"3004_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1471-4922(03)00028-X","volume":"19","author":"H Noedl","year":"2003","unstructured":"Noedl H, Wongsrichanalai C, Wernsdorfer WH: Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 2003, 19: 175-181. 10.1016\/S1471-4922(03)00028-X.","journal-title":"Trends Parasitol"},{"key":"3004_CR13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1128\/JCM.02250-09","volume":"48","author":"S Wein","year":"2010","unstructured":"Wein S, Maynadier M, Tran Van Ba C, Cerdan R, Peyrottes S, Fraisse L, Vial H: Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. J Clin Microbiol. 2010, 48: 1651-1660. 10.1128\/JCM.02250-09.","journal-title":"J Clin Microbiol"},{"key":"3004_CR14","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M: Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004, 48: 1803-1806. 10.1128\/AAC.48.5.1803-1806.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"3004_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.exppara.2008.05.003","volume":"120","author":"L Cui","year":"2008","unstructured":"Cui L, Miao J, Wang J, Li Q, Cui L: Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter. Exp Parasitol. 2008, 120: 80-87. 10.1016\/j.exppara.2008.05.003.","journal-title":"Exp Parasitol"},{"key":"3004_CR16","doi-asserted-by":"publisher","first-page":"e13653","DOI":"10.1371\/journal.pone.0013653","volume":"5","author":"S Helm","year":"2010","unstructured":"Helm S, Lehmann C, Nagel A, Stanway RR, Horstmann S, Llinas M, Heussler VT: Identification and characterization of a liver stage-specific promoter region of the malaria parasite Plasmodium. PLoS One. 2010, 5: e13653-10.1371\/journal.pone.0013653.","journal-title":"PLoS One"},{"key":"3004_CR17","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1128\/AAC.00431-10","volume":"54","author":"E Lucumi","year":"2010","unstructured":"Lucumi E, Darling C, Jo H, Napper AD, Chandramohanadas R, Fisher N, Shone AE, Jing H, Ward SA, Biagini GA, DeGrado WF, Diamond SL, Greenbaum DC: Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay. Antimicrob Agents Chemother. 2010, 54: 3597-3604. 10.1128\/AAC.00431-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"3004_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwall P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"key":"3004_CR19","doi-asserted-by":"publisher","first-page":"e30949","DOI":"10.1371\/journal.pone.0030949","volume":"7","author":"LM Sanz","year":"2012","unstructured":"Sanz LM, Crespo B, De-C\u00f3zar C, Ding XC, Llergo JL, Burrows JN, Garc\u00eda-Bustos JF, Gamo F-J: P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action. PLoS One. 2012, 7: e30949-10.1371\/journal.pone.0030949.","journal-title":"PLoS One"},{"key":"3004_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.ijpara.2012.08.010","volume":"42","author":"B Russell","year":"2012","unstructured":"Russell B, Suwanarusk R, Malleret B, Costa FT, Snounou G, Baird JK, Nosten F, R\u00e9nia L: Human ex vivo studies on asexual Plasmodium vivax: the best way forward. Int J Parasitol. 2012, 42: 1063-1070. 10.1016\/j.ijpara.2012.08.010.","journal-title":"Int J Parasitol"},{"key":"3004_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpara.2011.10.011","volume":"42","author":"C Borlon","year":"2012","unstructured":"Borlon C, Russell B, Sriprawat K, Suwanarusk R, Erhart A, Renia L, Nosten F, D\u2019Alessandro U: Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture. Int J Parasitol. 2012, 42: 155-160. 10.1016\/j.ijpara.2011.10.011.","journal-title":"Int J Parasitol"},{"key":"3004_CR22","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2011-04-348748","volume":"118","author":"B Russell","year":"2011","unstructured":"Russell B, Suwanarusk R, Borlon C, Costa FT, Chu CS, Rijken MJ, Sriprawat K, Warter L, Koh EG, Malleret B, Colin Y, Bertrand O, Adams JH, D\u2019Alessandro U, Snounou G, Nosten F, R\u00e9nia L: A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood. 2011, 118: e74-81. 10.1182\/blood-2011-04-348748.","journal-title":"Blood"},{"key":"3004_CR23","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1128\/AAC.00682-13","volume":"57","author":"B Russell","year":"2013","unstructured":"Russell B, Malleret B, Suwanarusk R, Anthony C, Kanlaya S, Lau Y, Woodrow C, Nosten F, Renia L: Field based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity. Antimicrob Agents Chemother. 2013, 57: 5170-5174. 10.1128\/AAC.00682-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"3004_CR24","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/AAC.50.4.1586-1589.2006","volume":"50","author":"A Gego","year":"2006","unstructured":"Gego A, Silvie O, Franetich JF, Farhati K, Hannoun L, Luty AJ, Sauerwein RW, Boucheix C, Rubinstein E, Mazier D: New approach for high-throughput screening of drug activity on Plasmodium liver stages. Antimicrob Agents Chemother. 2006, 50: 1586-1589. 10.1128\/AAC.50.4.1586-1589.2006.","journal-title":"Antimicrob Agents Chemother"},{"key":"3004_CR25","doi-asserted-by":"publisher","first-page":"e18162","DOI":"10.1371\/journal.pone.0018162","volume":"6","author":"L Dembele","year":"2011","unstructured":"Dembele L, Gego A, Zeeman AM, Franetich JF, Silvie O, Rametti A, Le Grand R, Dereuddre-Bosquet N, Sauerwein R, van Gemert GJ, Vaillant JC, Thomas AW, Snounou G, Kocken CH, Mazier D: Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One. 2011, 6: e18162-10.1371\/journal.pone.0018162.","journal-title":"PLoS One"},{"key":"3004_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.chom.2013.06.005","volume":"14","author":"S March","year":"2013","unstructured":"March S, Ng S, Velmurugan S, Galstian A, Shan J, Logan DJ, Carpenter AE, Thomas D, Sim BK, Mota MM, Hoffman SL, Bhatia SN: A Microscale Human Liver Platform that Supports the Hepatic Stages of Plasmodium falciparum and vivax. Cell Host Microbe. 2013, 14: 104-115. 10.1016\/j.chom.2013.06.005.","journal-title":"Cell Host Microbe"},{"key":"3004_CR27","doi-asserted-by":"publisher","first-page":"e14275","DOI":"10.1371\/journal.pone.0014275","volume":"5","author":"R Chattopadhyay","year":"2010","unstructured":"Chattopadhyay R, Velmurugan S, Chakiath C, Andrews Donkor L, Milhous W, Barnwell JW, Collins WE, Hoffman SL: Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. PLoS One. 2010, 5: e14275-10.1371\/journal.pone.0014275.","journal-title":"PLoS One"},{"key":"3004_CR28","doi-asserted-by":"publisher","first-page":"e54888","DOI":"10.1371\/journal.pone.0054888","volume":"8","author":"A Voorberg-van der Wel","year":"2013","unstructured":"Voorberg-van der Wel A, Zeeman AM, van Amsterdam SM, van den Berg A, Klooster EJ, Iwanaga S, Janse CJ, van Gemert GJ, Sauerwein R, Beenhakker N, Koopman G, Thomas AW, Kocken CH: Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of malaria hypnozoite-forms. PLoS One. 2013, 8: e54888-10.1371\/journal.pone.0054888.","journal-title":"PLoS One"},{"key":"3004_CR29","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","volume":"334","author":"S Meister","year":"2011","unstructured":"Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA: Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science. 2011, 334: 1372-1377. 10.1126\/science.1211936.","journal-title":"Science"},{"key":"3004_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1475-2875-12-187","volume":"12","author":"J Burrows","year":"2013","unstructured":"Burrows J, Hooft van Huijsduijnen R, Mohrle J, Oeuvray C, Wells T: Designing the next generation of medicines for malaria control and eradication. Malar J. 2013, 12: 187-10.1186\/1475-2875-12-187.","journal-title":"Malar J"},{"key":"3004_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/CMR.00051-10","volume":"24","author":"T Bousema","year":"2011","unstructured":"Bousema T, Drakeley C: Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011, 24: 377-410. 10.1128\/CMR.00051-10.","journal-title":"Clin Microbiol Rev"},{"key":"3004_CR32","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.4155\/fmc.12.188","volume":"4","author":"L Lucantoni","year":"2012","unstructured":"Lucantoni L, Avery V: Whole-cell in vitro screening for gametocytocidal compounds. Future Med Chem. 2012, 4: 2337-2360. 10.4155\/fmc.12.188.","journal-title":"Future Med Chem"},{"key":"3004_CR33","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1086\/644645","volume":"200","author":"CL Peatey","year":"2009","unstructured":"Peatey CL, Skinner-Adams TS, Dixon MW, McCarthy JS, Gardiner DL, Trenholme KR: Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J Infect Dis. 2009, 200: 1518-1521. 10.1086\/644645.","journal-title":"J Infect Dis"},{"key":"3004_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1475-2875-9-49","volume":"9","author":"S Chevalley","year":"2010","unstructured":"Chevalley S, Coste A, Lopez A, Pipy B, Valentin A: Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes. Malar J. 2010, 9: 49-10.1186\/1475-2875-9-49.","journal-title":"Malar J"},{"key":"3004_CR35","doi-asserted-by":"publisher","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","volume":"108","author":"SH Adjalley","year":"2011","unstructured":"Adjalley SH, Johnston GL, Li T, Eastman RT, Ekland EH, Eappen AG, Richman A, Sim BK, Lee MC, Hoffman SL, Fidock DA: Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci USA. 2011, 108: E1214-1223. 10.1073\/pnas.1112037108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3004_CR36","doi-asserted-by":"publisher","first-page":"e35019","DOI":"10.1371\/journal.pone.0035019","volume":"7","author":"J Lelievre","year":"2012","unstructured":"Lelievre J, Almela MJ, Lozano S, Miguel C, Franco V, Leroy D, Herreros E: Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence \u201ctransmission blocking\u201d assay. PLoS One. 2012, 7: e35019-10.1371\/journal.pone.0035019.","journal-title":"PLoS One"},{"key":"3004_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.molbiopara.2011.09.002","volume":"180","author":"CL Peatey","year":"2011","unstructured":"Peatey CL, Spicer TP, Hodder PS, Trenholme KR, Gardiner DL: A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol Biochem Parasitol. 2011, 180: 127-131. 10.1016\/j.molbiopara.2011.09.002.","journal-title":"Mol Biochem Parasitol"},{"key":"3004_CR38","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/infdis\/jir037","volume":"203","author":"K Buchholz","year":"2011","unstructured":"Buchholz K, Burke TA, Williamson KC, Wiegand RC, Wirth DF, Marti M: A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J Infect Dis. 2011, 203: 1445-1453. 10.1093\/infdis\/jir037.","journal-title":"J Infect Dis"},{"key":"3004_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.molbiopara.2011.02.005","volume":"177","author":"TQ Tanaka","year":"2011","unstructured":"Tanaka TQ, Williamson KC: A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. Mol Biochem Parasitol. 2011, 177: 160-163. 10.1016\/j.molbiopara.2011.02.005.","journal-title":"Mol Biochem Parasitol"},{"key":"3004_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.molbiopara.2013.02.005","volume":"188","author":"TQ Tanaka","year":"2013","unstructured":"Tanaka TQ, Dehdashti SJ, Nguyen D-T, McKew JC, Zheng W, Williamson KC: A quantitative high throughput assay for identifying gametocytocidal compounds. Mol Biochem Parasitol. 2013, 188: 20-25. 10.1016\/j.molbiopara.2013.02.005.","journal-title":"Mol Biochem Parasitol"},{"key":"3004_CR41","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/jac\/dkt165","volume":"68","author":"S D\u2019Alessandro","year":"2013","unstructured":"D\u2019Alessandro S, Silvestrini F, Dechering K, Corbett Y, Parapini S, Timmerman M, Galastri L, Basilico N, Sauerwein R, Alano P, Taramelli D: A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. J Antimicrob Chemother. 2013, 68: 2048-2058. 10.1093\/jac\/dkt165.","journal-title":"J Antimicrob Chemother"},{"key":"3004_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4269\/ajtmh.2012.11-0302","volume":"86","author":"S Duffy","year":"2012","unstructured":"Duffy S, Avery VM: Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening. Am J Trop Med Hyg. 2012, 86: 84-92. 10.4269\/ajtmh.2012.11-0302.","journal-title":"Am J Trop Med Hyg"},{"key":"3004_CR43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ijpara.2012.08.009","volume":"42","author":"MJ Delves","year":"2012","unstructured":"Delves MJ, Ramakrishnan C, Blagborough AM, Leroy D, Wells TNC, Sinden RE: A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines. Int J Parasitol. 2012, 42: 999-1006. 10.1016\/j.ijpara.2012.08.009.","journal-title":"Int J Parasitol"},{"key":"3004_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pt.2012.07.005","volume":"28","author":"RE Sinden","year":"2012","unstructured":"Sinden RE, Blagborough AM, Churcher T, Ramakrishnan C, Biswas S, Delves MJ: The design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium. Trends Parasitol. 2012, 28: 457-465. 10.1016\/j.pt.2012.07.005.","journal-title":"Trends Parasitol"},{"key":"3004_CR45","doi-asserted-by":"publisher","first-page":"e1001169","DOI":"10.1371\/journal.pmed.1001169","volume":"9","author":"M Delves","year":"2012","unstructured":"Delves M, Plouffe D, Scheurer C, Meister S, Wittlin S, Winzeler EA, Sinden RE, Leroy D: The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med. 2012, 9: e1001169-10.1371\/journal.pmed.1001169.","journal-title":"PLoS Med"},{"key":"3004_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S0031182004006067","volume":"130","author":"M van der Kolk","year":"2005","unstructured":"van der Kolk M, De Vlas SJ, Saul A, van de Vegte-Bolmer M, Eling WM, Sauerwein RW: Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology. 2005, 130: 13-22. 10.1017\/S0031182004006067.","journal-title":"Parasitology"},{"key":"3004_CR47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ijpara.2012.09.002","volume":"42","author":"TS Churcher","year":"2012","unstructured":"Churcher TS, Blagborough AM, Delves M, Ramakrishnan C, Kapulu MC, Williams AR, Biswas S, Da DF, Cohuet A, Sinden RE: Measuring the blockade of malaria transmission\u2013an analysis of the standard membrane feeding assay. Int J Parasitol. 2012, 42: 1037-1044. 10.1016\/j.ijpara.2012.09.002.","journal-title":"Int J Parasitol"},{"key":"3004_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2004.04.007","volume":"137","author":"B Franke-Fayard","year":"2004","unstructured":"Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, van der Linden R, Sinden RE, Waters AP, Janse CJ: A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol. 2004, 137: 23-33. 10.1016\/j.molbiopara.2004.04.007.","journal-title":"Mol Biochem Parasitol"},{"key":"3004_CR49","doi-asserted-by":"publisher","first-page":"e36376","DOI":"10.1371\/journal.pone.0036376","volume":"7","author":"C Ramakrishnan","year":"2012","unstructured":"Ramakrishnan C, Rademacher A, Soichot J, Costa G, Waters AP, Janse CJ, Ramesar J, Franke-Fayard BM, Levashina EA: Salivary gland-specific P. berghei reporter lines enable rapid evaluation of tissue-specific sporozoite loads in mosquitoes. PLoS One. 2012, 7: e36376-10.1371\/journal.pone.0036376.","journal-title":"PLoS One"},{"key":"3004_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"F Gamo","year":"2010","unstructured":"Gamo F, Sanz L, Vidal J, de Cozar C, Alvarez E, Lavandera J, Vanderwall D, Green D, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF: Thousands of chemical starting points for antimalarial lead identification. Nature. 2010, 465: 305-310. 10.1038\/nature09107.","journal-title":"Nature"},{"key":"3004_CR51","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1462-5822.2011.01582.x","volume":"13","author":"A Sicard","year":"2011","unstructured":"Sicard A, Semblat JP, Doerig C, Hamelin R, Moniatte M, Dorin-Semblat D, Spicer JA, Srivastava A, Retzlaff S, Heussler V, Waters AP, Doerig C: Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes. Cell Microbiol. 2011, 13: 836-845. 10.1111\/j.1462-5822.2011.01582.x.","journal-title":"Cell Microbiol"},{"key":"3004_CR52","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1371\/journal.pmed.0030528","volume":"3","author":"SC Murphy","year":"2006","unstructured":"Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, Haldar K: Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med. 2006, 3: e528-10.1371\/journal.pmed.0030528.","journal-title":"PLoS Med"},{"key":"3004_CR53","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1475-2875-10-S1-S2","volume":"10","author":"E Guantai","year":"2011","unstructured":"Guantai E, Chibale K: How can natural products serve as a viable source of lead compounds for the development of new\/novel anti-malarials?. Malar J. 2011, 10: S2-10.1186\/1475-2875-10-S1-S2.","journal-title":"Malar J"},{"key":"3004_CR54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mas.20235","volume":"29","author":"KW Cheng","year":"2010","unstructured":"Cheng KW, Wong CC, Wang M, He QY, Chen F: Identification and characterization of molecular targets of natural products by mass spectrometry. Mass Spectrom Rev. 2010, 29: 126-155.","journal-title":"Mass Spectrom Rev"},{"key":"3004_CR55","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1039\/B713022H","volume":"6","author":"M Pucheault","year":"2008","unstructured":"Pucheault M: Natural products: chemical instruments to apprehend biological symphony. Org Biomol Chem. 2008, 6: 424-432. 10.1039\/b713022h.","journal-title":"Org Biomol Chem"},{"key":"3004_CR56","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1017\/S0031182010000260","volume":"137","author":"E Holmes","year":"2010","unstructured":"Holmes E: The evolution of metabolic profiling in parasitology. Parasitology. 2010, 137: 1437-1449. 10.1017\/S0031182010000260.","journal-title":"Parasitology"},{"key":"3004_CR57","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","volume":"13","author":"AL Harvey","year":"2008","unstructured":"Harvey AL: Natural products in drug discovery. Drug Discov Today. 2008, 13: 894-901. 10.1016\/j.drudis.2008.07.004.","journal-title":"Drug Discov Today"},{"key":"3004_CR58","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/anie.200905352","volume":"49","author":"T Bottcher","year":"2010","unstructured":"Bottcher T, Pitscheider M, Sieber SA: Natural products and their biological targets: proteomic and metabolomic labeling strategies. Angew Chem Int Ed Engl. 2010, 49: 2680-2698. 10.1002\/anie.200905352.","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T06:48:25Z","timestamp":1716101305000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,5]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-396","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,5]]},"assertion":[{"value":"17 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"396"}}